Selank 10mg + Semax 10mg

Preclinical and mechanistic studies have shown that Semax and Selank influence molecular pathways involved in central nervous system function. Research has demonstrated that both peptides inhibit human serum enkephalin-degrading enzymes. This suggests a potential role in modulating endogenous peptide signalling and providing a useful model for investigating metabolism and neurochemical processes.

Experimental studies have also examined the effects of Semax and Selank on functional brain connectivity. Resting-state functional MRI analyses identified distinct and overlapping patterns of connectivity involving the amygdala and dorsolateral prefrontal cortex. These findings support the continued investigation of Semax and Selank as a multi-peptide research blend for studying brain network organization and neurophysiological signalling.

This product is intended exclusively for laboratory research and is suitable for studies of:

• Neuropeptide biology
• Neurotransmitter regulation
• Peptide–enzyme interactions
• Intracellular signalling
• Neuroimmune mechanisms
• Functional brain connectivity